Thrombocythemia Drug Market Progresses for Huge Profits by the End 2025
Thrombocythemia is also referred as essential thrombocythemia or primary thrombocythemia. Thrombocythemia is a rare chronic blood clotting disorder caused by bone marrow. It is a condition in which blood has higher platelets compare to normal platelets. The normal range of platelet in human blood is 150,000 to 450,000 per microliter. Blood clots can occur suddenly in patients suffering from thrombocythemia. Abnormal blood clotting can be fatal as it may block the flow of blood to the heart, brain, liver, or...
View full press release